相关实验视频

Updated: Feb 14, 2026

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

通过将OLIG2抑制剂CT-179与分离辐射结合起来,针对儿科质母细胞瘤,在一个由患者衍生的正位素异体移植小鼠模型小组中进行分离辐射

Holly Lindsay^1,2, Yuchen Du^1,3, Lin Qi^1,3,4

¹Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, USA.

International journal of molecular sciences

|February 13, 2026

概括

OLIG2 抑制剂 CT-179 显示为治疗儿科高度质瘤 (pHGG) 的前景. 这种药物穿透了血脑屏障,当与放射治疗相结合时,可以改善pHGG患者的生存率.

科学领域:

神经瘤学神经瘤学
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

儿科高度质瘤 (pHGG) 的临床结果不佳,需要新的治疗策略.
橄腺细胞谱系转录因子2 (OLIG2) 在质瘤干细胞中表达高,是潜在的治疗点.
目前正在评估OLIG2抑制剂CT-179在pHGG治疗中的有效性.

研究的目的:

评估OLIG2抑制剂CT-179在儿科高度质瘤 (pHGG) 模型中的治疗疗效.
在患者衍生的正位异种移植 (PDOX) 模型中确定OLIG2mRNA表达.
评估CT-179的体外和体内活性,包括其透大脑和与放射治疗 (XRT) 的结合效应.

主要方法:

在十个PDOX模型中确定了OLIG2mRNA表达.
评估CT-179在单层和神经圈细胞的体外活性,有或没有XRT.
评估了CT-179在携带瘤的PDOX小鼠的大脑透率及其单独和XRT的体内疗效.
使用卡普兰-梅尔方法分析了生存数据.

主要成果:

在十个PDOX模型中的七个中发现了增加的OLIG2mRNA表达.
CT-179以剂量和时间依赖的方式抑制细胞活力,其活性由XRT强化.
在小鼠中,CT-179有效透到大脑和PDOX瘤中.
在四个模型中,CT-179与XRT相结合,在两种模型中显著延长了动物的生存时间.

结论:

口服CT-179可以穿透血脑屏障.
CT-179显示出抑制pHGG生长的潜力,特别是与XRT结合使用时.
需要进一步研究CT-179作为pHGG的治疗剂.

关键词:

在GBMGBMGBMGBMGBM 在OLIG2中,OLIG2是OLIG2的前身.PDOXX PDOXX 在线阅读儿科大脑瘤儿科大脑瘤辐射辐射辐射辐射的辐射治疗疗效治疗疗效治疗疗效

更多相关视频

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

Published on: December 20, 2024

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

相关概念视频

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

Wood Panel Products

Wood Panel Products

Wood panel products are essential materials used in construction for applications such as flooring, siding, and roofing, typically available in standard dimensions of 4 feet by 8 feet, with thicknesses varying from one-quarter of an inch to one and one-eighth inches. Among the most common types of wood panels is plywood, which is produced by gluing multiple layers of thin wood veneers under pressure. The grain of the outer veneers runs lengthwise, while the grains of the interior layers run...

Biological Effects of Radiation

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...